Unifast Activated Partial Thromboplastin Time Test
by Sclavo, Inc. 510(k)
Active
510(k) K882325
Regulatory status
| Region | Authorization | Number | Date | Status |
|---|---|---|---|---|
| United States | FDA 510(k)SESE | NumberK882325 | Date25 Aug 1988 | StatusActive |
Coverage
- Active
- Expiring
- Withdrawn
- Listed
- Not covered
United States — FDA 510(k) Active
Recalls
No FDA recalls on record, checked 22 Oct 2026.
Specification
- 510(k) Number
- FDA Product Code
- GFO
- Device Class
- Class II
- Regulation
- 21 CFR Part 864.7925
- Advisory Committee
- Hematology
- FDA Decision
- SESE Substantially Equivalent
Overview
AI-generated summary, 25 Sep 2026
The Unifast Activated Partial Thromboplastin Time Test is an in vitro diagnostic device used to measure the activated partial thromboplastin time. This test is categorized under hematology and is designed for clinical laboratory use.
This device is regulated as a Class 2 medical device under regulation number 864.7925. It received FDA 510(k) clearance on August 25, 1988, under submission number K882325.
Other devices from Sclavo, Inc.
Questions
AI-generated answers, 25 Sep 2026
What is the primary clinical use of the Unifast test?
The Unifast Activated Partial Thromboplastin Time Test is an in vitro diagnostic device intended for clinical laboratory use to measure the activated partial thromboplastin time, which is a standard hematology assessment.
How is this device classified for regulatory purposes?
This device is regulated as a Class 2 medical device under regulation number 864.7925. It received FDA 510(k) clearance on August 25, 1988, under submission number K882325, confirming it is substantially equivalent to predicate devices.
Which medical specialty does this test fall under?
The Unifast test is categorized under the hematology medical specialty, as indicated by its product code GFO and its review by the Hematology advisory committee.